- Dental implant provider lands growth investment
- Specialty1 Partners appoints VP of business development
- ‘Much needed clarity and a path to restore trust’: Fairview, U of Minnesota, M Physicians close in on new 10-year deal
- Maryland dental practice acquires 2nd office
- Physicians are not ‘providers’: AMA
- Stanford’s AI discharge summary tool cuts physician burnout
- Optum to cut 92 jobs in California
- R1 RCM names former Humana executive CIO
- 2 Oregon practices merge, creating one of state’s largest physician-owned groups
- 3 states take aim at private equity in healthcare
- UPMC lays off 200 workers, cuts 300 positions
- Google develops passive heart rate monitoring via smartphone camera
- Why AdventHealth thinks it can sell an internal insurance model to employers
- AHA: Hospitals lean on technology to make healthcare more affordable
- How Oceans Healthcare is scaling behavioral care — starting with the ER
- South Dakota health system names 2 executives
- 5 ASC leaders to know
- GLP-1 drugs tied to 75% lower substance use disorder odds: 4 notes
- When physician groups hit the wall: 3 turnaround stories
- 7 updates from Park Dental Partners since its IPO
- House Appropriations Committee takes aim at CMS' WISeR pilot
- How general dentist pay compares to 25 healthcare roles
- 14 state behavioral health policy updates
- Who’s snatching up DSOs?
- The missed colonoscopy problem ASCs can no longer afford to ignore
- PCMA unveils new policy platform aimed at drug affordability
- DEA finalizes OUD treatment rule: What it means for behavioral healthcare
- CalOptima Health approves $430M rate increase to keep safety-net providers afloat
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- HCA Surgery Ventures names supply chain CEO
- 15 neurosurgeons to know
- CRNA pay is up 59% since 2019: 5 reasons why
- GLP-1s tied to lower risk of multiple cancers
- University of Pittsburgh dental school to open 3rd training center
- Colorado ‘screened out’ 92% of youth center abuse hotline calls: 5 things to know
- ASCs’ hidden efficiency drain
- Dental College of Georgia dean dies
- SF General, UCSF fined after social worker’s fatal stabbing
- Penn Medicine ED program boosts naltrexone prescriptions 15-fold
- Hundreds of hospitals warned over price transparency failings, AP reports
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- Cleveland Clinic agrees to 'decades-long' halt on gender-affirming care for minors in DOJ settlement
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals
- Clinicians report AI use expands patient capacity, boosts efficiency: Philips survey
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AstraZeneca reprimanded over LinkedIn likes once again
- FDA Expands Sunscreen Options for the First Time in 20 Years
- 29 behavioral health executive moves to know
- 3 states where dental hygienist pay dropped
- 5 states where dental assistant pay dropped
- ‘No disruptions’: Elevance study backs take-home methadone
- Dartmouth Health targets treatment gap for pregnant patients with SUD
- From affordability to engagement, these are the topics to watch at AHIP 2026
- Accrediting bodies, more medical schools commit to RFK Jr.'s nutrition education pledge
- Children's Well-Being Plummets Across 29 States, Report Finds
- Senate HELP committee chairman seeks info on NYC Health + Hospital data breach
- ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes
- With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race
- CVS launched an AI Learning Academy for its workforce. Here's why
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Sophia Genetics, Memorial Sloan Kettering sign strategic collab for AI-powered precision oncology hub
- ‘Law & Order’ star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Cities sue Trump administration to block final ACA rule
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi
- Upcoming Billing Change Could Make Pregnancy Pricier
- MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy
- By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying
- Hikma earmarks $267M to expand pair of Ohio production sites, add 350 jobs
- Stepful banks $55M to scale AI-powered medical training to boost the workforce pipeline
- ADA: Amgen highlights Repatha perks, GLP-1 pitfalls in push to boost cardiometabolic pedigree
- Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
- Untreated Cancer, Festering Infections: Immigrant Detainees Detail Medical Care Lapses
- Elation Health acquires Aster as it ramps up agentic AI for primary care
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Essence Healthcare, Oura expand partnership to sleep apnea detection
- Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
- Industry Voices—A healthcare experience that is as seamless as it is soulful
- Fullspan Health debuts Healthline AI companion to connect consumers to medical content and providers
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- Behind the headlines of ASCO 2026
- RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines
- Two-Pill Combo, Inqovi and Venclexta, Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
- ‘We Live With Fear’: In Congo, Doctors Face Ebola With Little Protection
- Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite
- Upcoming Billing Change Could Make Pregnancy Pricier
- At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Weekly Rundown: Trump signs AI executive order; Health Catalyst to sell Vitalware for $147M
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
- Remarks at the Investor Advisory Committee Meeting
- Fierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
- ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta
- As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Axsome fends off generic competition to narcolepsy med Sunosi until 2040
- Menopause Hormone Therapy Use Drops Sharply Across United States
- Michigan Found A Way To Reduce School Vaccine Waivers — Until It Backfired
- Listen to the Latest ‘KFF Health News Minute’
- 8 Requirements for AI Medical Interpreting: 2026 Survey Results
- Healthcare Dealmakers—WakeMed to join Atrium Health, Qualtrics closes $6.8B Press Ganey deal and more
- Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
- Just 90 Minutes Of Strength Training A Week Linked To Longer Life
- Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
- Urine Test Can Detect Autism, Study Says
- High-Puff Vapes Become More Toxic Over Time, Study Says
- GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
- Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
- Base Case: Remarks at the IC3 Blockchain Camp
- Trump Signs Order Calling For Fewer Childhood Vaccines
- Simple Blood Test May Help Detect And Stage Alzheimer's Disease
- Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
- Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- CAT on a Hot Tin Roof
Michigan healthcare freedom community forum
KFF Health News has posted a story on NPR's All Things Considered which posits that seniors find themselves trapped in their specific Medicare Advantage plans as they develop additional conditions which require additional health care which may not be covered in their Medicare Advantage plan directory:
Older Americans say they feel trapped in Medicare Advantage plans
By Sarah Jane Tribble - January 3, 2024In 2016, Richard Timmins went to a free informational seminar to learn more about Medicare coverage.
"I listened to the insurance agent, and basically, he really promoted Medicare Advantage," Timmins says. The agent described less expensive and broader coverage offered by the plans, which are funded largely by the government but administered by private insurance companies.
For Timmins, who is now 76, it made economic sense then to sign up. And his decision was great, for a while.
Then, three years ago, he noticed a lesion on his right earlobe.
"I have a family history of melanoma. And so, I was kind of tuned in to that and thinking about that," Timmins says of the growth, which doctors later diagnosed as malignant melanoma. "It started to grow and started to become rather painful."
Timmins, though, discovered that his enrollment in a Premera Blue Cross Medicare Advantage plan would mean a limited network of doctors and the potential need for preapproval, or prior authorization, from the insurer before getting care. The experience, he says, made getting care more difficult, and now he wants to switch back to traditional, government-administered Medicare.
But he can't. And he's not alone.
"I have very little control over my actual medical care," he says, adding that he now advises friends not to sign up for the private plans. "I think that people are not understanding what Medicare Advantage is all about."
Enrollment in Medicare Advantage plans has grown substantially in the past few decades, enticing more than half of eligible people, primarily those 65 or older, with low premium costs and perks like dental and vision insurance. And as the private plans' share of the Medicare patient pie has ballooned to 30.8 million people, so too have concerns about the insurers' aggressive sales tactics and misleading coverage claims.
Enrollees, like Timmins, who sign on when they are healthy can find themselves trapped as they grow older and sicker.
"It's one of those things that people might like them on the front end because of their low to zero premiums and if they are getting a couple of these extra benefits — the vision, dental, that kind of thing," says Christine Huberty, a lead benefit specialist supervising attorney for the Greater Wisconsin Agency on Aging Resources.
"But it's when they actually need to use it for these bigger issues," Huberty says, "that's when people realize, 'Oh no, this isn't going to help me at all.'"
Medicare pays private insurers a fixed amount per Medicare Advantage enrollee and in many cases also pays out bonuses, which the insurers can use to provide supplemental benefits. Huberty says those extra benefits work as an incentive to "get people to join the plan" but that the plans then "restrict the access to so many services and coverage for the bigger stuff."
David Meyers, assistant professor of health services, policy and practice at the Brown University School of Public Health, analyzed a decade of Medicare Advantage enrollment and found that about 50% of beneficiaries — rural and urban — left their contract by the end of five years. Most of those enrollees switched to another Medicare Advantage plan rather than traditional Medicare.
In the study, Meyers and his co-authors muse that switching plans could be a positive sign of a free marketplace but that it could also signal "unmeasured discontent" with Medicare Advantage.
"The problem is that once you get into Medicare Advantage, if you have a couple of chronic conditions and you want to leave Medicare Advantage, even if Medicare Advantage isn't meeting your needs, you might not have any ability to switch back to traditional Medicare," Meyers says.
Traditional Medicare can be too expensive for beneficiaries switching back from Medicare Advantage, he says. In traditional Medicare, enrollees pay a monthly premium and, after reaching a deductible, in most cases are expected to pay 20% of the cost of each nonhospital service or item they use. And there is no limit on how much an enrollee may have to pay as part of that 20% coinsurance if they end up using a lot of care, Meyers says.
To limit what they spend out-of-pocket, traditional Medicare enrollees typically sign up for supplemental insurance, such as employer coverage, or a private Medigap policy. If they are low income, Medicaid may provide that supplemental coverage.
But, Meyers says, there's a catch: While beneficiaries who enrolled first in traditional Medicare are guaranteed to qualify for a Medigap policy without pricing based on their medical history, Medigap insurers can deny coverage to beneficiaries transferring from Medicare Advantage plans or base their prices on medical underwriting.
Only four states — Connecticut, Maine, Massachusetts and New York — prohibit insurers from denying a Medigap policy if the enrollee has preexisting conditions such as diabetes or heart disease.
Paul Ginsburg is a former commissioner on the Medicare Payment Advisory Commission, also known as MedPAC. It's a legislative branch agency that advises Congress on the Medicare program. He says the inability of enrollees to easily switch between Medicare Advantage and traditional Medicare during open enrollment periods is "a real concern in our system; it shouldn't be that way."
The federal government offers specific enrollment periods every year for switching plans. During Medicare's open enrollment period, from Oct. 15 to Dec. 7, enrollees can switch out of their private plans to traditional, government-administered Medicare.
Medicare Advantage enrollees can also switch plans or transfer to traditional Medicare during another open enrollment period, from Jan. 1 to March 31.
"There are a lot of people that say, 'Hey, I'd love to come back, but I can't get Medigap anymore, or I'll have to just pay a lot more,'" says Ginsburg, who is now a professor of health policy at the University of Southern California.
Timmins is one of those people. The retired veterinarian lives in a rural community on Whidbey Island just north of Seattle. It's a rugged, idyllic landscape and a popular place for second homes, hiking, and the arts. But it's also a bit remote.
While it's typically harder to find doctors in rural areas, Timmins says he believes his Premera Blue Cross plan made it more challenging to get care for a variety of reasons, including the difficulty of finding and getting in to see specialists.
Nearly half of Medicare Advantage plan directories contained inaccurate information on what providers were available, according to the most recent federal review. Beginning in 2024, new or expanding Medicare Advantage plans must demonstrate compliance with federal network expectations or their applications could be denied.
Amanda Lansford, a Premera Blue Cross spokesperson, declined to comment on Timmins' case. She says the plan meets federal network adequacy requirements as well as travel time and distance standards "to ensure members are not experiencing undue burdens when seeking care."
Traditional Medicare allows beneficiaries to go to nearly any doctor or hospital in the U.S., and in most cases enrollees do not need approval to get services.
Timmins, who recently finished immunotherapy, says he doesn't think he would be approved for a Medigap policy, "because of my health issue." And if he were to get into one, Timmins says, it would likely be too expensive.
For now, Timmins said, he is staying with his Medicare Advantage plan.
"I'm getting older. More stuff is going to happen."
There is also a chance, Timmins says, that his cancer could resurface: "I'm very aware of my mortality."
A relative recently did a rehab stint for a foot injury and the rehab where she went said they recently hired some special type of therapist to help make therapy more efficient because the Medicare Advantage plans are reducing the amount of time they get with patients. They have to accomplish as much as they have in the past with less time to do it.
@pattie maybe one of the new doctor-level PTs?
That's the latest practice entry standard for PTs.
Because more education means more efficient, right?
It is so sad to hear that clinician-patient time is to be reduced even more. Crazy times.
@mhf I don't remember the title for the new specialist. It could be the dr level PT.
I was talking with some coworkers about doctor's appointments, and we agreed that the commute to get to the doctor often lasts longer than the appointment with the doctor these days.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















